Total Payments
$15,878
2024 Payments
$199.58
Companies
12
Transactions
29
Medicare Patients
6,481
Medicare Billing
$273,601
Payment Breakdown by Category
Consulting$14,730 (92.8%)
Food & Beverage$629.02 (4.0%)
Research$519.44 (3.3%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $14,730 | 3 | 92.8% |
| Food and Beverage | $629.02 | 25 | 4.0% |
| Unspecified | $519.44 | 1 | 3.3% |
Payments by Type
General
$15,359
28 transactions
Research
$519.44
1 transactions
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Astellas Pharma Global Development | $15,249 | 4 | $0 (2017) |
| Novartis Pharmaceuticals Corporation | $154.14 | 10 | $0 (2024) |
| Abbott Laboratories | $125.44 | 1 | $0 (2021) |
| Actelion Pharmaceuticals US, Inc. | $110.19 | 1 | $0 (2024) |
| Novo Nordisk Inc | $48.85 | 3 | $0 (2023) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $43.75 | 3 | $0 (2022) |
| Amgen Inc. | $36.21 | 2 | $0 (2024) |
| LANTHEUS MEDICAL IMAGING, INC. | $26.24 | 1 | $0 (2024) |
| E.R. Squibb & Sons, L.L.C. | $25.88 | 1 | $0 (2017) |
| PFIZER INC. | $25.77 | 1 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $199.58 | 5 | Actelion Pharmaceuticals US, Inc. ($110.19) |
| 2023 | $41.31 | 2 | Novartis Pharmaceuticals Corporation ($24.75) |
| 2022 | $136.07 | 9 | Novartis Pharmaceuticals Corporation ($57.31) |
| 2021 | $152.31 | 3 | Abbott Laboratories ($125.44) |
| 2020 | $25.32 | 2 | Novartis Pharmaceuticals Corporation ($25.32) |
| 2019 | $16.00 | 1 | Novartis Pharmaceuticals Corporation ($16.00) |
| 2018 | $17.31 | 1 | Lundbeck LLC ($17.31) |
| 2017 | $15,291 | 6 | Astellas Pharma Global Development ($15,249) |
All Payment Transactions
29 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/13/2024 | PFIZER INC. | VYNDAQEL (Drug) | Food and Beverage | In-kind items and services | $25.77 | General |
| Category: CARDIOVASCULAR | ||||||
| 09/26/2024 | Actelion Pharmaceuticals US, Inc. | UPTRAVI (Drug), OPSUMIT | Food and Beverage | In-kind items and services | $110.19 | General |
| Category: Cardiology | ||||||
| 09/17/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $19.30 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 08/08/2024 | LANTHEUS MEDICAL IMAGING, INC. | DEFINITY (Drug) | Food and Beverage | In-kind items and services | $26.24 | General |
| Category: CONTRAST AGENT | ||||||
| 03/12/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $18.08 | General |
| Category: Cardiology | ||||||
| 08/31/2023 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug), ENTRESTO | Food and Beverage | In-kind items and services | $24.75 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 08/07/2023 | Novo Nordisk Inc | Ozempic (Drug) | Food and Beverage | In-kind items and services | $16.56 | General |
| Category: Diabetes | ||||||
| 11/28/2022 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $18.13 | General |
| Category: Cardiology | ||||||
| 11/08/2022 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $15.59 | General |
| Category: DIABETES | ||||||
| 10/17/2022 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug), LEQVIO | Food and Beverage | In-kind items and services | $16.30 | General |
| Category: CARDIOVASCULAR | ||||||
| 08/29/2022 | Novo Nordisk Inc | Saxenda (Drug), Wegovy | Food and Beverage | In-kind items and services | $12.42 | General |
| Category: Obesity | ||||||
| 08/13/2022 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $19.87 | General |
| Category: Diabetes | ||||||
| 08/02/2022 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $12.75 | General |
| Category: DIABETES | ||||||
| 04/27/2022 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $12.83 | General |
| Category: CARDIOVASCULAR | ||||||
| 03/04/2022 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug), LEQVIO | Food and Beverage | In-kind items and services | $12.94 | General |
| Category: CARDIOVASCULAR | ||||||
| 01/24/2022 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug), LEQVIO | Food and Beverage | In-kind items and services | $15.24 | General |
| Category: CARDIOVASCULAR | ||||||
| 09/07/2021 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $15.41 | General |
| Category: DIABETES | ||||||
| 08/03/2021 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $11.46 | General |
| Category: CARDIOVASCULAR | ||||||
| 05/26/2021 | Abbott Laboratories | CardioMEMS HF System (Device) | Food and Beverage | In-kind items and services | $125.44 | General |
| Category: Heart Failure | ||||||
| 08/25/2020 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $12.68 | General |
| Category: CARDIOVASCULAR | ||||||
| 01/31/2020 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $12.64 | General |
| Category: CARDIOVASCULAR | ||||||
| 11/05/2019 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $16.00 | General |
| Category: CARDIOVASCULAR | ||||||
| 07/19/2018 | Lundbeck LLC | NORTHERA (Drug) | Food and Beverage | Cash or cash equivalent | $17.31 | General |
| Category: NEUROLOGY | ||||||
| 12/13/2017 | Astellas Pharma Global Development | Lexiscan (Drug) | Consulting Fee | Cash or cash equivalent | $2,730.00 | General |
| Category: Cardiology | ||||||
| 07/12/2017 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $25.88 | General |
| Category: Cardiovascular | ||||||
Research Studies & Clinical Trials
| Study Name | Company | Amount | Records |
|---|---|---|---|
| A retrospective study of variation in hospital utilization of diagnostic cardiac testing using an acute care hospital database for patients having cardiac biomarker testing and presenting in the emergency room | Astellas Pharma Global Development | $519.44 | 1 |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 21 | 1,850 | 2,078 | $203,305 | $74,468 |
| 2022 | 19 | 1,666 | 1,882 | $177,307 | $65,173 |
| 2021 | 25 | 1,627 | 1,867 | $183,489 | $73,872 |
| 2020 | 21 | 1,338 | 1,522 | $160,067 | $60,088 |
Total Patients
6,481
Total Services
7,349
Medicare Billing
$273,601
Procedure Codes
86
All Medicare Procedures & Services
86 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 280 | 343 | $64,141 | $28,802 | 44.9% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Facility | 2023 | 268 | 271 | $40,108 | $13,348 | 33.3% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 54 | 54 | $15,714 | $5,904 | 37.6% |
| 78452 | Nuclear medicine studies of heart muscle at rest and with stress and spect | Facility | 2023 | 84 | 84 | $13,020 | $4,432 | 34.0% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 300 | 370 | $15,910 | $3,588 | 22.6% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 36 | 38 | $9,310 | $3,522 | 37.8% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 37 | 49 | $8,967 | $3,012 | 33.6% |
| 93010 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | Facility | 2023 | 271 | 344 | $6,192 | $2,035 | 32.9% |
| 93016 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision by physician | Facility | 2023 | 115 | 115 | $5,290 | $1,734 | 32.8% |
| 99221 | Initial hospital care with straightforward or low level of medical decision making, per day, if using time, at least 40 minutes | Facility | 2023 | 26 | 26 | $5,070 | $1,574 | 31.0% |
| 93312 | Ultrasound of heart with probe in esophagus, with report | Facility | 2023 | 14 | 14 | $2,940 | $1,164 | 39.6% |
| 92960 | External shock to heart to regulate heart beat | Facility | 2023 | 14 | 15 | $3,840 | $1,108 | 28.9% |
| 93018 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | Facility | 2023 | 108 | 110 | $3,300 | $1,102 | 33.4% |
| 93308 | Ultrasound of heart, follow-up | Facility | 2023 | 52 | 52 | $2,600 | $932.64 | 35.9% |
| 78431 | Nuclear medicine studies of blood flow in heart muscle at rest and with stress with concurrent ct scan | Facility | 2023 | 12 | 12 | $2,208 | $689.70 | 31.2% |
| 93280 | Programming of dual lead pacemaker system | Office | 2023 | 17 | 17 | $1,459 | $450.28 | 30.9% |
| 93321 | Ultrasound of heart blood flow, valves and chambers, follow-up | Facility | 2023 | 53 | 54 | $864.00 | $280.50 | 32.5% |
| 93320 | Ultrasound of heart blood flow, valves and chambers | Facility | 2023 | 18 | 18 | $684.00 | $249.12 | 36.4% |
| 78434 | Nuclear medicine study of heart muscle blood flow by pet | Facility | 2023 | 12 | 12 | $744.00 | $238.74 | 32.1% |
| 93356 | Heart muscle strain imaging | Facility | 2023 | 19 | 19 | $456.00 | $163.26 | 35.8% |
| 93325 | Ultrasound of heart with color-depicted blood flow, rate and valve function | Facility | 2023 | 60 | 61 | $488.00 | $138.38 | 28.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 279 | 345 | $64,515 | $28,773 | 44.6% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Facility | 2022 | 244 | 246 | $36,408 | $11,432 | 31.4% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 44 | 44 | $12,804 | $5,120 | 40.0% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2022 | 316 | 394 | $16,942 | $3,817 | 22.5% |
About Dr. Daniel Mudrick, MD
Dr. Daniel Mudrick, MD is a Internal Medicine healthcare provider based in Circleville, Ohio. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/16/2006. The National Provider Identifier (NPI) number assigned to this provider is 1457378325.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Daniel Mudrick, MD has received a total of $15,878 in payments from pharmaceutical and medical device companies, with $199.58 received in 2024. These payments were reported across 29 transactions from 12 companies. The most common payment nature is "Consulting Fee" ($14,730).
As a Medicare-enrolled provider, Mudrick has provided services to 6,481 Medicare beneficiaries, totaling 7,349 services with total Medicare billing of $273,601. Data is available for 4 years (2020–2023), covering 86 distinct procedure/service records.
Ad
Practice Information
- Specialty Internal Medicine
- Other Specialties Internal Medicine, Internal Medicine
- Location Circleville, OH
- Active Since 07/16/2006
- Last Updated 01/05/2022
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1457378325
Products in Payments
- Lexiscan (Drug) $14,730
- Regadenoson (Drug) $519.44
- CardioMEMS HF System (Device) $125.44
- UPTRAVI (Drug) $110.19
- ENTRESTO (Drug) $97.26
- LEQVIO (Drug) $56.88
- JARDIANCE (Drug) $43.75
- Repatha (Biological) $36.21
- DEFINITY (Drug) $26.24
- ELIQUIS (Drug) $25.88
- VYNDAQEL (Drug) $25.77
- Rybelsus (Drug) $19.87
- NORTHERA (Drug) $17.31
- Ozempic (Drug) $16.56
- Ranexa (Drug) $15.24
- Saxenda (Drug) $12.42
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Circleville
Dr. Gregory Lam, M.d, M.D
Internal Medicine — Payments: $392,860
Internal Medicine $392,860
Dr. Lisette Dominguez, Do, DO
Internal Medicine — Payments: $87,391
Internal Medicine $87,391
Yadwinder Singh, Md, MD
Internal Medicine — Payments: $1,141
Internal Medicine $1,141
Allen Reeves
Internal Medicine — Payments: $766.53
Internal Medicine $766.53
Arnold Palmer, Do, DO
Internal Medicine — Payments: $611.39
Internal Medicine $611.39
Robert Violette, D.o, D.O
Internal Medicine — Payments: $572.68
Internal Medicine $572.68